Entheogen is a Boston-based private corporation. Our BOL-148 is undergoing clinical trials for the effective treatment of chronic cluster headache. Our initial clinical data suggest BOL-148 is an important first-in-class medication for cluster headache with unique treatment properties not achieved by any currently approved medications.